Company / Operating Margin
Crinetics Pharmaceuticals, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-6714.8%
FY2025
5-year range
-32613.5% / -3544.1%
FY2021-FY2025
Trend
+79.4%
vs FY2024
Sector context
#132 of 136
Health Care
What the data says
Among 136 Health Care companies, Crinetics Pharmaceuticals, Inc. is in the bottom 3% for operating margin. Operating Margin has fluctuated over the past 8 years, ranging from -32613.5% in FY2024 to -446.3% in FY2019.
Based on SEC 10-K filings.
-6714.8% in FY2025 with a 5-year CAGR of -5532.3%.
Declined from -3544.1% to -6714.8% over the past 3 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -3170.7pp
- 5-Year Change
- -5532.3pp
- 10-Year Change
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 136This company -6714.8% Sector average -778.9%
▼
-762.0% below sector average
Key checks
Key Insights
- In FY2025, operating margin increased 79.4% year-over-year.
- Currently 5935.8pp below the Health Care sector average.
- Peak operating margin was recorded in FY2019.
- Lowest operating margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -6714.8% | +79.4% |
| FY2024 | -32613.5% | - |
| FY2023 | - | - |
| FY2022 | -3544.1% | +64.5% |
| FY2021 | -9990.9% | -744.9% |
| FY2020 | -1182.5% | -164.9% |
| FY2019 | -446.3% | +56.5% |
| FY2018 | -1026.2% | - |
| FY2017 | - | - |
| FY2016 | -1026.2% | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026